KAS-ATAC: Mapping Accessible ssDNA in Chromatin

The protocol paper Mapping the Simultaneously Accessible and ssDNA-Containing Genome With KAS-ATAC Sequencing presents a detailed implementation of KAS-ATAC, an assay designed to measure two DNA states in the same genomic fragments. The method combines chromatin accessibility profiling with chemical detection of single-stranded DNA (ssDNA), providing information that is not available from conventional ATAC-seq alone.

This distinction is important because open chromatin and active transcription are related but not identical. Nucleosome-depleted regulatory elements are accessible to Tn5 transposase, whereas RNA polymerase engagement can create short-lived ssDNA bubbles. KAS-ATAC seeks the intersection of these signals, making it useful for interpreting where accessible chromatin is also associated with transcription-related DNA structures. The article was published in Bio-protocol in 2025 and focuses on protocol execution and basic data analysis rather than presenting a new biological atlas.

Study Background and Research Question

Gene regulation depends on the coordinated activity of promoters, enhancers, insulators, and transcription factors. Active cis-regulatory elements are often depleted of nucleosomes, a property that allows enzymatic assays to detect them. ATAC-seq established a particularly efficient strategy by using hyperactive Tn5 transposase to cleave accessible DNA and insert sequencing adapters in the same reaction.

Accessibility alone, however, does not identify the molecular activity occurring at an open region. A promoter or enhancer may be accessible but transcriptionally inactive, while a transcribed region may contain polymerase-associated DNA structures that are not directly resolved by ATAC-seq. Run-on assays such as GRO-seq and PRO-seq address transcriptional activity, but they measure nascent RNA and generally require a separate experimental workflow.

KAS-seq provides a complementary chemical readout. N3-kethoxal, also known as 3-(2-azidoethoxy)-1,1-dihydroxybutan-2-one, reacts covalently with exposed guanine bases in unpaired DNA. The resulting azide-bearing adduct can undergo bioorthogonal click chemistry labeling, enabling selective enrichment of DNA fragments that contained ssDNA. The research question behind KAS-ATAC is therefore practical and specific: can accessibility and ssDNA be recorded together from native chromatin so that accessible regulatory DNA can be separated from accessible DNA associated with transcription or other ssDNA-generating events?

Key Innovation from the Reference Study

The central innovation is the integration of two established measurement principles into one fragment-level assay. ATAC-seq contributes information about physical accessibility, while KAS chemistry contributes information about unpaired guanine residues. In KAS-ATAC, a fragment is most informative when it carries evidence for both properties.

This design adds an activity-sensitive layer to standard chromatin accessibility profiling. A conventional ATAC-seq peak can indicate that nucleosomes are displaced or that DNA is exposed, but it does not by itself establish that an RNA polymerase has generated an ssDNA bubble. Conversely, KAS-seq can mark ssDNA-containing regions but does not necessarily indicate that the surrounding chromatin is broadly accessible. KAS-ATAC narrows interpretation toward genomic locations where these conditions coincide.

The method is especially relevant to transcription-associated chromatin. RNA polymerases locally separate the DNA strands during elongation and pausing, creating the type of unpaired DNA that KAS chemistry can detect. The reference protocol also recognizes that ssDNA can arise from replication intermediates and DNA secondary structures. Thus, KAS-ATAC should be interpreted as a combined accessibility and ssDNA assay, not as a direct, exclusive measurement of transcription rate or polymerase occupancy.

A further conceptual strength is that the chemical label is covalent and can be installed before downstream processing. This makes the ssDNA signal compatible with subsequent tagmentation, enrichment, and sequencing-library preparation. The permanent tag also supports broader multiomic designs, although those extensions require their own validation and should not be assumed from the basic KAS-ATAC workflow.

Methods and Experimental Design Insights

The experimental logic follows a sequence of chemical labeling, chromatin transposition, affinity enrichment, and sequencing. Native chromatin is first exposed to N3-kethoxal so that accessible unpaired guanines can be covalently modified. The azide group is then converted into a biotin-containing handle through click chemistry. Tn5 transposition is performed on the labeled chromatin, allowing accessible DNA fragments to receive sequencing adapters. Biotin-containing fragments are subsequently recovered by pulldown and amplified into sequencing libraries.

Maintaining the native chromatin context is important. Excessive DNA purification or denaturation could alter the relationship between nucleosome occupancy, polymerase-associated bubbles, and other transient DNA structures. Similarly, the timing of labeling and transposition must preserve both the chemical mark and the physical accessibility state that the assay is intended to measure.

Protocol Parameters

• Chromatin state: Use native chromatin as the substrate so that accessibility and ssDNA are assessed in their cellular structural context; this is a reference-protocol feature rather than a substitute for optimization in every cell type.
• N3-kethoxal labeling: Apply the probe before library construction to covalently mark exposed guanine residues in ssDNA regions. Reaction conditions should be selected to preserve chromatin integrity and minimize nonspecific background.
• Bioorthogonal conversion: Use click chemistry to attach biotin to the azide-bearing DNA adduct, creating an affinity handle for selective recovery.
• Tn5 transposition: Transpose the labeled native chromatin to tag accessible fragments with sequencing adapters. The resulting library retains the intersection between accessibility and prior ssDNA labeling.
• Biotin pulldown: Enrich biotin-labeled DNA fragments before amplification. This step is central to separating KAS-positive material from the broader transposed chromatin pool.
• Library processing: Perform adapter trimming, quality assessment, alignment, duplicate handling, and signal visualization using a workflow appropriate for ATAC-like data, while retaining comparisons between total accessible and KAS-enriched fractions.

The protocol paper emphasizes that successful implementation depends on careful handling of labeling, transposition, pulldown efficiency, and library complexity. In practice, researchers should include an ATAC-seq-compatible input or unenriched fraction, assess enrichment over background, and interpret signal together with genomic annotation. These are workflow recommendations for robust interpretation; they should be evaluated alongside the controls and optimization guidance in the published protocol.

Core Findings and Why They Matter

The principal finding is methodological: KAS-ATAC can map genomic fragments that are simultaneously accessible and ssDNA-containing. This creates a useful partition of regulatory DNA. Regions with strong ATAC signal but weak KAS enrichment may represent accessible cis-regulatory elements without substantial detectable ssDNA, whereas regions positive in both channels are more consistent with accessibility coupled to polymerase-associated or otherwise exposed single-stranded structures.

This combined readout improves the interpretation of chromatin maps. It can help researchers distinguish structural openness from a biochemical state associated with transcriptional engagement. The assay is therefore relevant to studies of promoter activity, enhancer transcription, paused polymerase, and the organization of regulatory elements, provided that the resulting signal is not treated as uniquely diagnostic of one mechanism.

The approach also offers an efficient bridge between chromatin and transcription measurements. Rather than requiring separate assays to identify open chromatin and nascent transcription, KAS-ATAC places both types of information on compatible DNA fragments. That feature may be valuable when sample quantity, cell-state matching, or direct comparison between modalities is a major experimental constraint.

Comparison with Existing Internal Articles

The internal article N3-kethoxal (A8793): Reliable Probing for RNA & DNA Accessibility provides a broader discussion of N3-kethoxal chemistry and nucleic-acid accessibility workflows. It complements the reference protocol by placing the reagent in a wider experimental context, whereas the Marinov and Greenleaf article is more narrowly focused on native chromatin, ssDNA capture, transposition, enrichment, and KAS-ATAC data processing.

The distinction matters for literature interpretation. General claims about an azide-functionalized nucleic acid probe should not be confused with evidence generated by KAS-ATAC itself. The reference study directly supports the combined mapping of accessible and ssDNA-containing genomic fragments; applications such as RNA secondary structure probing or RNA-protein interaction identification require separate assay designs, controls, and validation.

Limitations and Transferability

KAS-ATAC does not provide a pure transcription map. Although RNA polymerase bubbles are a major biological source of genomic ssDNA, replication intermediates, DNA secondary structures, and other unusual conformations can also contribute to KAS signal. A positive fragment therefore indicates accessibility plus chemical evidence of exposed guanine in ssDNA, not necessarily a specific polymerase state.

Signal intensity is also influenced by several technical variables, including probe access, guanine composition, reaction completeness, click-labeling efficiency, pulldown recovery, transposition bias, and sequencing depth. A guanine-poor ssDNA region may be underrepresented even if it is biologically important. Conversely, inefficient removal of unbound or nonspecifically retained material can reduce the contrast between KAS-positive and background fragments.

Cell type and chromatin preparation are additional sources of variation. Fragile nuclei, unusual ploidy, high replication activity, or strong DNA damage responses may change the abundance and distribution of ssDNA. Comparisons between conditions should therefore use matched processing and appropriate input controls. Peak overlap should be interpreted with genomic context, strand information where available, transcription annotations, and independent evidence rather than as a standalone mechanistic conclusion.

Why this cross-domain matters, maturity, and limitations

The underlying N3-kethoxal chemistry is also relevant to RNA secondary structure probing and to studies seeking RNA-protein interaction identification, because unpaired guanines can report on exposed nucleic-acid structure. However, the evidence in the reference article concerns DNA in native chromatin, not a validated RNA structure-mapping or proximity-identification protocol. Moving from KAS-ATAC to RNA applications changes substrate accessibility, folding behavior, nuclease sensitivity, and background chemistry. Those applications should therefore be treated as adjacent possibilities supported by the chemical principle, not as direct findings of this paper.

Within its validated scope, KAS-ATAC is a mature protocol-level extension of ATAC-seq and KAS-seq concepts. Its strongest use is comparative genomic analysis in which accessibility and ssDNA-associated signal are measured under matched conditions. Its interpretation is weakest when the assay is used without controls to assign a single molecular cause to every KAS-enriched region.

Research Support Resources

For researchers adapting this workflow, the reference protocol is the primary resource for experimental sequencing and basic KAS-ATAC analysis. Researchers can use N3-kethoxal (SKU A8793) to support similar ssDNA-labeling and downstream bioorthogonal click chemistry workflows, with final reaction conditions determined by the biological system and assay controls.